Horizon Therapeutics (United States)

Horizon Therapeutics (United States)

Horizon Therapeutics plc was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Horizon Therapeutics (United States), United States, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

63%


Total
Publications

337


Total Open
Publications

213


Total
Citations

6.5K


Open Access
Percentage

63%


Total
Publications

337


Total Open
Publications

213


Total
Citations

6.5K

Wikipedia

Website

download

Breakdown

29% 28% 5% 38%

Publisher Open

29%

Both

28%

Other Platform Open

5%

Closed

38%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530354045505560Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

38%OA Journal

OA Journal 38%

70

Hybrid 22%

41

No Guarantees 40%

75

Other Platform Open

Domain 86%

95

Other Internet 13%

14

Institution 9%

10

Preprint 2%

2

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
95
DOI
Other Internet
14
Research Square
Preprint
2
Europe PMC
Domain
2
Utrecht University
Institution
1
University of Turin
Institution
1
University of Modena and Reggio Emilia
Institution
1
University of Michigan–Ann Arbor
Institution
1
University of Groningen
Institution
1
Swiss School of Archaeology in Greece
Institution
1
1 / 2

Data updated 18 August 2025

Share

Share

Share